Kategorie: joimax® News

joimax® turns 15 years

Veröffentlicht am von Antonio Berlen

Karlsruhe, Germany and Chicago, Illinois (April 30, 2016) – joimax®, the global acting German developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, is celebrating its 15th anniversary worldwide in 2016 starting at AANS in Chicago combined with a joimax® Senior Faculty Meeting. The aim of this meeting is to share experience, deepen expertise, specifically in reference to the newest joimax® products and applications as well as to refine the specific surgical techniques. Key topics will be centered around endoscopic treatment of degenerative spine diseases.

“When I started with the TESSYS® system in 2006 I was wondering at which patient indications this system could be applied”, says Daniel Laich, DO at Swedish Covenant Hospital in Chicago, Il.
“Now we are doing all kind of special stenotic cases and even thoracic disc, or even tumor treatments”, continues Albert Telfeian, MD, PhD at the Hasbro Hospital of The Warren Alpert Medical School at Brown University, Rhode Island.
“With the iLESSYS® Delta System I can even do an over-the-top decompression in a central stenotic patient and with the EndoLIF® method I do an endoscopic assisted stabilization if indicated” finishes Ralf Wagner, MD from the Ligamenta Spine Center in Frankfurt, Germany.

joimax®, entirely focused on treatment technologies for endoscopic minimally-invasive spinal surgery, over the years launched more than 10 different indication driven systems providing a company growth rate of over 35% per annum. To date more than 180.000 patients had been treated in over 40 countries with the various methods, based on more than 140 patents and trademarks issued globally. “The major company growth and market evolutional steps are further out in front of the companies’ future, based on solid ground with broad market adoption starting just now”, states Wolfgang Ries, CEO and founder of joimax®.

User Meeting Heidelberg

Veröffentlicht am von Antonio Berlen

joimax® sets the second highlight in its anniversary year: The TESSYS®/iLESSYS® User Meeting in Heidelberg

Karlsruhe/Heidelberg, 20 June 2011. After the success of the User Meeting in scope of the AANS Annual Scientific Meeting in Denver, Colorado in April, joimax® invited customers and users of their systems to attend the User Meeting in Heidelberg.

Teilnehmer Anwendertreffen Heidelberg 2011

 

The meeting provided an ideal discussion forum for the TESSYS® users, orthopedic and neurosurgeons with scientific lectures, experience reports and an extensive practical session at the Institute for Anatomy and Cell Biology of the Heidelberg University. joimax® placed the focus on their new products with the shaver/drill system SHRILL® and the iLESSYS® instrument kits, that represent the consistent further development of the well-known and proven joimax® platform for endoscopic spine surgery. Dr. med. Carl Hans Fu?rstenberg, Senior Consultant and Deputy Head of Spinal Cord Injury and Head of Operative Spinal Cord Injury Department of Orthopaedics, Trauma Surgery and Spinal Cord Injury at the University Hospital Heidelberg, was impressed with the, now comprehensive, access technique: „The circle has been literally closed now. With TESSYS® and iLESSYS® we have the 360 degrees access to the spinal canal.“ „With the complement of iLESSYS® for interlaminar access, the complete range of endoscopic access techniques to the spinal canal is now available, providing us a lot more options to help patients efficiently and fast “, stated University Lecturer Dr. Sandro Eustacchio from the Neurosurgery Department of the University Hospital in Graz, Austria, who has been practicing the interlaminar access method for quite a while and demonstrated it to the audience.

Another core theme was the application of the shaver/drill system SHRILL®, impressively presented by Dr. med. Guntram Krzok, Friedrichroda, who cannot imagine specifically stenosis therapy without this „fantastic instrument“ any more, as he stated. According to his experience, this instrument perfectly completes the indication array of endoscopic spinal surgery.

All participants praised the format of the meeting with being the right mix of theory and practice as well as the ideal forum for an extensive exchange of experiences between the experts. During the relevant congresses and exhibitions of the second half of 2011, joimax® will present and launch further product novelties starting at EuroSpine in Milan, Italy, and SMISS in Las Vegas in October, NASS in Chicago in November and later at the 6th German Spine Congress to be held in Hamburg in December 2011.

joimax® Organizes its First Online Endoscopic Spine Symposium

Veröffentlicht am von Antonio Berlen

Karlsruhe (GER) — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online global symposium, “Endoscopic Spine Surgery – Indications, Technology and Limitations”, at its headquarters in the Training and Education Center (TEC) in Karlsruhe-Germany, on April 24-25, 2020.

In view of the coronavirus restrictions introduced by many governments, in March,  joimax® began holding weekly webinars, in partnership with key surgeons, to demonstrate the latest endoscopic techniques. The training sessions culminated with a two-day Symposium, full of live discussions and video demonstrations, scheduled during Western and Eastern time zones.

On April 24, joimax® Founder and CEO Wolfgang Ries, moderated a panel with faculty members Ralf Wagner, MD (Ligamenta Spine Center Frankfurt-Germany) and Christoph Hofstetter, MD, PhD (University of Washington Medicine, Neurosurgery Department, Seattle/USA). The following day, faculty member, Junseok Bae, MD (President of Wooridul Spine Hospital Seoul, South Korea), joined the panel.

On both days, the agenda included a theoretical part focused on transforaminal and interlaminar indications, and the general possibilities of endoscopy from lumbar to thoracic to cervical, as well as a hands-on lab portion. In the wet lab, Dr. Ralf Wagner demonstrated the joimax® product application of TESSYS® and iLESSYS® in specific indications. Moreover, there were presentations of Intracs® em , the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip. This navigation system combines lateral and AP images of the C-arm with CT scan, providing surgeons with most accurate views of the target region.

The Symposium also featured special guests: Dr. Menno Iprenburg (Iprenburg Spine Clinic, Veenhuizen, Netherlands) and Prof. Alastair Gibson (The Royal Infirmary of Edinburgh, Edinburgh Scotland); both board members of ESPINEA® Academy, who gave their valued input, based on their long-lasting experience.

“This is the  future of digital education and a great way to virtually meet and learn,” stated Dr. Iprenburg.  Prof. Gibson added, “excellent Symposium; it couldn’t get any better”.

The Symposium marked a major milestone, with 430 participants. Surgeons from all over the world joined this unique online education program and stimulating Q&A session.

When safe, joimax® will transition back to on-site workshops and trainings, but in the  meantimewill continue with its attention-grabbing online webinars.

joimax® – The experts in minimally invasive endoscopic spinal surgery show flag at the EUROSPINE in Lyon

Veröffentlicht am von Antonio Berlen

Karlsruhe – joimax® is participating with an industrial exhibition at the annual meeting of the european spine society „EUROSPINE“ from October 1st to October 3rd at the Congress Center in Lyon. In Forum N° A43 the company, located in Karlsruhe, exhibits its now highly diversified product portfolio for 360° surgery in nearly all areas of the spine including endoscopic or percutaneous stabilization. In various lunch symposia, numerous european experts will show their experiences and results. During a 2 hours lunch symposium on the first day of the Congress in Hall Rhône 1 internationally recognized spine specialists under the leadership of Dr. Menno Iprenburg (Veenhuizen / Netherlands) and Dr. Alastair Gibson (Edinburgh / United Kingdom) will provide insights of their experience and into their scientific results.

Lectures on the latest product developments are expected with great interest, hereby:

  • The EndoLIF® system for endoscopic lumbar column stabilization. This system includes not only the fully endoscopic access technology to the disc space with the proven TESSYS® or iLESSYS® method, but also an implant, the so-called O-Cage (O = oblique).
  • Percusys®, an innovative screw and rod system for the posterior percutaneous stabilization.

The advantages of this methods are obvious:

  • Tissue sparing access by dilation
  • Protection of dura and nerves through a proven access corridor
  • Preservation of the posterior bony structures due to the special lateral access
  • EndoLIF® O-Cage made of Ti6Al4V for optimized bone ingrowth
  • Percutaneous stabilization by Percusys® and therefore minimally invasive

Both new systems are CE approved and the FDA approval is in progress.

Since 2004, more than 100,000 patients in 30 countries were successfully operated using the TESSYS® method and their further developments. Studies show the shorter reconvalescence time, faster recovery and thereby speed up the return of the patients to work and enhance quality of life.

Visit joimax® at EUROSPINE, Cité Internationale, Lyon Convention Centre, Forum N° A 43 and see for yourself the benefits of the new systems.

joimax® shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

Veröffentlicht am von Antonio Berlen

Karlsruhe, Germany – January 17th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax® procedures.

joimax® is active in 45 countries by now and meanwhile enjoys a strong reputation in Europe and also in Asia which will now spread out into the US-market as well. “The entry in force of the CPT 2017 reimbursement Codebook (Current Procedural Terminology) as of January 1st, 2017, is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques. The codebook now contains the first endoscopic spinal surgery code, under which the specific transforaminal (TESSYS®) and/or interlaminar (iLESSYS®) procedures marketed by joimax® are now eligible in the USA and this will further contribute to fully increase sales in the US as well” states Wolfgang Ries, Founder and CEO of joimax®.

joimax® technologies are based on worldwide intellectual property and the company holds now more than 150 patents and trademarks. Only in 2016 18 patents and patent publications were issued to joimax®. The latest one is Patent No. EP 2 983 622 for the EndoLIF® Cage, which has been introduced to offer a minimally invasive as well as open (TLIF) alternative for fusion in the lumbar spine as an optimal treatment option for surgeons.

The company is busy on inventing and innovating next minimally invasive systems with regards to newer implants based on the EndoLIF® technology but also decompression methods based on its endoscopic systems. This will now be completed with Intracs®, the new Interaoperative Navigation Tracking & Control System with which joimax® instruments can be navigated directly at the tip. The Intracs® Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF® (Lumbar Interbody Fusion) and Percusys® (Percutaneous Screw-Rod Stabilization).

Orthopedics This Week – October 2012

Veröffentlicht am von Antonio Berlen

Anthony Yeung, M.D., receives the Parviz Kambin Award of the Society for Minimally Invasive Spine Surgery (SMISS) in cooperation with joimax® for his outstanding achievements in the field of minimally-invasive endoscopic spinal surgery.

Yeung Honored by SMISS

Anthony Yeung, M.D., known to his many friends and admirers as “Tony,” is the 2012 recipient of the Parviz Kambin Award, given by the Society for Minimally Invasive Spine Surgery (SMISS) to honor outstanding surgeons in the field of endoscopic spine surgery. The Society held the ceremony during its annual meeting, September 23, and Yeung’s son, Christopher Yeung, M.D., accepted the award for his father.

SMISS established the Kambin Award, in collaboration with joimax®, to recognize the surgeons who have successfully performed more than 1,000 cases of endoscopic spinal surgery, trained more than 100 surgeons in the procedure, (in both cases specifically transforaminal surgery), published in numerous scientific publications and professional journals and given presentations at leading congresses. Finally, the recipient must demonstrate a strong commitment to clinical research and training. Choll Kim, M.D. and executive director, Society for Minimally Invasive Spine Surgery, wrote, “Tony is my hero and certainly deserves such an award.”

The award is named for Parviz Kambin, M.D. to recognize and honor his pioneering work that paved the way for minimally invasive endoscopic spine surgery. Kambin identified the unique safe access point to the spinal canal now known as the “Kambin Triangle.” Previous awardees are Parviz Kambin, M.D., professor of Orthopedic Surgery, Drexel University; Michael Schubert, M.D., APEX Spine Center, Munich, Germany; and Menno Iprenburg, M.D., Veenhuizen, Netherlands.

SMISS is the only society dedicated solely to advancing minimally invasive spine surgery. Endoscopic spine surgery constitutes but a small portion of SMISS’ overall educational content regarding minimally invasive spine surgery. SMISS’ primary role is to provide a forum for the exchange of ideas and information.

Orthopedics This Week – Yeung Honered by SMISS

Parviz Kambin Award 2012 ; minimally invasive spine surgery ; Joimax ; endoscopy
Yeung Honored by SMISS

joimax® ANNOUNCES STRATEGIC PARTNERSHIP WITH NAMSA

Veröffentlicht am von Antonio Berlen

Taps the market access professionals to oversee reimbursement strategy

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally-invasive spinal surgery, is pleased to announce a new strategic partnership with NAMSA, the only full continuum Contract Research Organization (CRO) in the world focused exclusively on medical devices. Recognized as a leader in reimbursement strategies, with years of experience in collaborating with public and private payors, Namsa will assist joimax®’ customers with reimbursement support services, including prior authorization and appeals support, across the United States.

“We are excited for NAMSA to serve as an exclusive partner to help patients access joimax®’ endoscopic technologies,” stated joimax® General Manager

Maximilian Ries. “We’re optimistic that with NAMSA’s assistance, and the nearly 5,000 clinical papers on endoscopic spine surgery, we will continue to expand coverage of this important, minimally-invasive technology”.

Since the creation of American Medical Association medical procedural code, CPT® 62380, Endoscopic Decompression of Neural Elements and/or Excision of Herniated Intervertebral Discs, in 2017, utilization of endoscopic spinal procedures has grown.

For details, visit www.joimax.com.

 

NASS, 2015: joimax® launches its new EndoLIF® On-Cage and new iLESSYS® Delta interlaminar endoscopy system

Veröffentlicht am von Antonio Berlen

Chicago, Illinois – October 14, 2015 (BUSINESS WIRE) – joimax®, the global German developer and marketer of technologies and training methods for minimally invasive endoscopic spinal surgery, launches its two newest products – the EndoLIF® On-Cage and iLESSYS® Delta interlaminar system, during the 30th annual North American Spine Society (NASS) meeting in Chicago.

“With the new EndoLIF® program, combined with the TESSYS® technology, and now the iLESSYS® Delta, joimax® offers complete endoscopic solutions for spinal decompression, stabilization and fusion.”

The EndoLIF® On-Cage is a 3D-printed titanium alloy, manufactured utilizing a special electron beam melting (EBM) technology. The cage displays a porous surface with a diamond cell structure, which provides an optimal base for cell proliferation and bone growth. Two large implant graft windows, which are filled with autogenous bone, allow for bridging bone to further support fusion. The EndoLIF® On-Cage implant allows surgeons to utilize a mini-open or an inter-muscular approach, similar to a mini-transforaminal lumbar interbody fusion (TLIF) approach, into the intervertebral disc space facilitating endoscopic-assisted fusion.

Dr. Ralf Wagner, LIGAMENTA Spine Center, Frankfurt, and Dr. Bernd Illerhaus, ONZ Spine Center, Recklinghausen, are two German spine specialists who have already performed more than 200 of the 800 EndoLIF® On-Cage procedures in Europe. “The access is dura and nerve-gentle, preserves better dorsal bony structures and limits scar tissue formation because of the stepwise tissue dilation,” said Dr. Wagner.

iLESSYS® Delta, an advanced development of the joimax iLESSYS® standard technology, is suitable for dorsal and dorso-lateral treatment of central spinal canal stenosis. The iLESSYS® Delta system enables a large area to be decompressed by means of a more widened interlaminar approach, guided by a full endoscopic direct visualization technique. The new and specific instrument set includes specially developed tools that permit an extensive, yet gentle, tissue-sparing decompression. A new endoscope with a 6 mm working channel allows the use of large shaver blades designed for bone and tissue resection, along with a range of instruments to be applied under full endoscopic view.

“We are impressed by the new endoscope which delivers outstanding image quality. With the specialized instrument set, it is finally possible to achieve decompression of central spinal canal stenosis,” said Albert E. Telfeian, M.D., Ph.D., Department of Neurosurgery, Rhode Island Hospital, Providence, RI. Jian Shen, MD, PhD, of Mohawk Valley Orthopedics, P.C., NY, concurs. The two surgeons gained experience with the new system during a meeting at the Anatomy Department of the University of Mainz, Germany, earlier this year, and during the cadaveric training course at Vitruvian lab in Baltimore, MD, held last week.

“Albert Telfeian and Jian Shen will be the first spinal surgeons in the USA to perform surgeries with the new iLESSYS® Delta endoscopic technology and the EndoLIF® On-Cage implants,” says Wolfgang Ries, CEO and founder of joimax®. He adds, “With the new EndoLIF® program, combined with the TESSYS® technology, and now the iLESSYS® Delta, joimax® offers complete endoscopic solutions for spinal decompression, stabilization and fusion.”

With the FDA approval of Percusys® percutaneous screw-rod-system earlier this year, and the FDA approval of EndoLIF® On-Cage in July, joimax® is positioning itself as a clear leader in minimally invasive endoscopic spinal surgery, providing a full spectrum of product technologies, now fully available in the U.S. market.

joimax® for the first time awards the Parviz Kambin prize in cooperation with SMISS in the frame of the first US TESSYS® User Meeting in Denver, Colorado.

Veröffentlicht am von Antonio Berlen

[29.04.2011] – Karlsruhe/Denver, Colorado, April 2011. After a very successful advanced cadaver workshop on Saturday, April 9, 2011, joimax® held its first US TESSYS® User Meeting on Sunday, April 10th in Denver, Colorado, the site of the Scientific Annual Meeting for AANS, the American Association of Neurological Surgeons.

In cooperation with SMISS, Society for Minimally Invasive Spine Surgery, joimax®, for the first time, presented the Parviz Kambin award to Dr. Parviz Kambin. Dr. Kambin is one of the most important pioneers who paved the way for the minimally invasive endoscopic spine surgery industry. The award was founded to honor outstanding surgeons in the field of endoscopic spine surgery. Dr. Parviz Kambin identified the unique safe access point to the spinal canal now known as the ‘Kambin triangle.’ Additionally, two experienced spinal surgeons, Dr. Michael Schubert, Munich, Germany and Dr. Menno Iprenburg, Veenhuizen, the Netherlands, were honored with the Parviz Kambin Award, each having performed more than 1.000 procedures of this kind, trained hundreds of doctors using the TESSYS® technique and each publishing scientific presentations held at renowned international congresses.

Winner_Kambin_Award_2011

Dr. Choll Kim, Executive Director of SMISS and Associate Clinical Professor of Orthopaedic Surgery at the University of California – San Diego, “We, at SMISS, consider endoscopy of the spine to be a progressive technique with huge potential for the future of minimally invasive spine surgery. Aside from their operative work, we recognize the accomplishments of the recipients, who are large contributors to the advancement of the TESSYS® procedure on a global level.”

Besides the highlight of the award presentation ceremony, the User Meeting offered a robust program of scientific presentations, reports and discussions with internationally renowned spine specialists in the field of orthopaedic and neuro surgery. Additionally, joimax® started its celebrating event program 2011: 5 years joimax® Inc. in the USA and 10 years joimax® GmbH in Germany.

joimax® Celebrates Resounding Success at the German Spine Society (DWG) Convention 2019

Veröffentlicht am von Antonio Berlen

Karlsruhe (GER) / Irvine, CA – December 3, 2019 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, celebrated resounding success at this year’s German Spine Society (DWG), held November 28 to 30 in Munich, Germany. joimax® presented its newest product innovations and hosted several informative sessions to rave reviews, exceeding expectations.

Among the products showcased was a new member of the joimax® TESSYS® family, TESSYS® Thx, a system specifically developed for the symptomatic thoracic deherniation and decompression treatment. Surgeries utilizing TESSYS® Thx can avoid complications often associated with traditional open and microsurgical approaches, such as significant muscle damage, bony resection, and morbidities.

joimax® also presented Intracs®em, the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip, if required. This navigation system combines side and AP images of the C-arm with the CT axial scan, providing surgeons with meaningful views of the target region. Intracs® em received its CE mark earlier this year and has been successful throughout Europe and Asia. FDA approval is pending; expected by year’s end.

Moreover, joimax® presented its Endoscopic Spine Academy ESPINEA®. This modular training program, divided into a Pre-Clinical Training with anatomical models, endoscopic tools, and simulators, and a Clinical Training, part of the joimax® CM3 program consisting of visitation, hands-on workshops, and the first surgery, offers surgeons specific support to optimize and significantly shorten the individual learning curve.

Additional highlights included, the daily Meet the Expert Sessions, a Needle Placement Challenge with attractive prizes, and a lunch symposium on “Endoscopy in the Course of Time”.

joimax® CEO and Founder Wolfgang Ries states, “Our unmatched attention to the needs of surgeons enables us to be one step ahead. The reception of our products at this convention reinforced our commitment to endoscopy and underscored the importance of showcasing innovative products such as Intracs®em.  By participating in national and international spine congresses, we are able to achieve broad market penetration for the benefit of the patient”.